Janet W. Andersen

3.6k total citations · 1 hit paper
47 papers, 2.6k citations indexed

About

Janet W. Andersen is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Janet W. Andersen has authored 47 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 12 papers in Pathology and Forensic Medicine and 12 papers in Oncology. Recurrent topics in Janet W. Andersen's work include Acute Myeloid Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and HIV/AIDS drug development and treatment (7 papers). Janet W. Andersen is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and HIV/AIDS drug development and treatment (7 papers). Janet W. Andersen collaborates with scholars based in United States, South Africa and United Arab Emirates. Janet W. Andersen's co-authors include Martin S. Tallman, Peter H. Wiernik, Jacob M. Rowe, Frederick R. Appelbaum, Charles A. Schiffer, James H. Feusner, Angela Ogden, Lois E. Shepherd, Cheryl L. Willman and Clara D. Bloomfield and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Janet W. Andersen

47 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

1997 806 citations Martin S. Tallman, Janet W. Andersen et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Janet W. Andersen United States	26	1.2k	1.1k	499	401	352	47	2.6k
Isaac Ben‐Bassat Israel	34	529 0.4×	1.3k 1.1×	587 1.2×	674 1.7×	282 0.8×	140	3.2k
Bruce Patterson Canada	32	772 0.7×	919 0.8×	1.2k 2.4×	1.3k 3.3×	333 0.9×	59	3.7k
Mark U. Rarick United States	23	356 0.3×	745 0.7×	1.3k 2.6×	628 1.6×	384 1.1×	48	2.7k
Mar Tormo Spain	32	1.3k 1.1×	2.1k 1.8×	646 1.3×	290 0.7×	187 0.5×	106	3.1k
Nicolaas Schaap Netherlands	39	1.0k 0.9×	2.1k 1.9×	1.5k 2.9×	107 0.3×	496 1.4×	152	4.6k
H. Wandt Germany	21	262 0.2×	683 0.6×	596 1.2×	495 1.2×	283 0.8×	48	1.9k
John K. Erban United States	26	567 0.5×	761 0.7×	1.8k 3.6×	353 0.9×	127 0.4×	62	3.9k
Shin Mineishi United States	36	1.0k 0.9×	1.8k 1.6×	1.6k 3.1×	163 0.4×	550 1.6×	163	4.2k
C. P. Engelfriet Netherlands	37	276 0.2×	3.2k 2.8×	229 0.5×	345 0.9×	253 0.7×	153	4.7k
Margaret O’Donnell United States	28	607 0.5×	2.2k 1.9×	1.1k 2.1×	394 1.0×	415 1.2×	91	3.4k

Countries citing papers authored by Janet W. Andersen

Since Specialization

Citations

This map shows the geographic impact of Janet W. Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet W. Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet W. Andersen more than expected).

Fields of papers citing papers by Janet W. Andersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet W. Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet W. Andersen. The network helps show where Janet W. Andersen may publish in the future.

Co-authorship network of co-authors of Janet W. Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Janet W. Andersen. A scholar is included among the top collaborators of Janet W. Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet W. Andersen. Janet W. Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hua, Lei, Janet W. Andersen, Eric S. Daar, et al.. (2013). Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment. AIDS. 27(17). 2725–2734. 24 indexed citations

Kemmer, Nyingi, Lei Hua, Janet W. Andersen, et al.. (2012). Health‐related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study. Journal of Viral Hepatitis. 19(11). 792–800. 13 indexed citations

Chung, Raymond T., Triin Umbleja, Jennifer Y. Chen, et al.. (2012). Extended Therapy With Pegylated Interferon and Weight-Based Ribavirin for HCV-HIV Coinfected Patients. HIV Clinical Trials. 13(2). 70–82. 9 indexed citations

Umbleja, Triin, et al.. (2011). The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirin. Alimentary Pharmacology & Therapeutics. 33(11). 1234–1244. 14 indexed citations

Sherman, Kenneth E., Janet W. Andersen, Adeel A. Butt, et al.. (2010). Sustained Long-Term Antiviral Maintenance Therapy in HCV/HIV-Coinfected Patients (SLAM-C). JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(5). 597–605. 20 indexed citations

Fife, Kenneth H., Julia Wu, Kathleen Squires, et al.. (2009). Prevalence and Persistence of Cervical Human Papillomavirus Infection in HIV-Positive Women Initiating Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(3). 274–282. 47 indexed citations

Cohn, Susan E., Triin Umbleja, Joseph Mrus, et al.. (2007). Prior Illicit Drug Use and Missed Prenatal Vitamins Predict Nonadherence to Antiretroviral Therapy in Pregnancy: Adherence Analysis A5084. AIDS Patient Care and STDs. 22(1). 29–40. 30 indexed citations

Kitch, Douglas, et al.. (2006). Predictors of Antiretroviral-Related Hepatotoxicity in the Adult AIDS Clinical Trial Group (1989-1999). JAIDS Journal of Acquired Immune Deficiency Syndromes. 43(3). 320–323. 58 indexed citations

Kendall, Michelle A., Janet W. Andersen, & Charles van der Horst. (2006). A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207. Contemporary Clinical Trials. 27(3). 287–294. 4 indexed citations

10.

MacGregor, Rob Roy, Richard Hafner, Julia Wu, et al.. (2005). Clinical, Microbiological, and Immunological Characteristics in HIV-Infected Subjects at Risk for Disseminated Mycobacterium avium Complex Disease: An AACTG Study. AIDS Research and Human Retroviruses. 21(8). 689–695. 8 indexed citations

11.

Bennett, J M, Mary Lynn Young, Janet W. Andersen, et al.. (1997). Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience.. PubMed. 80(11 Suppl). 2205–9. 95 indexed citations

12.

Clark, J., Paul M. Busse, Charles M. Norris, et al.. (1997). Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.. Journal of Clinical Oncology. 15(9). 3100–3110. 48 indexed citations

13.

Tallman, Martin S., Janet W. Andersen, Charles A. Schiffer, et al.. (1997). All-trans-Retinoic Acid in Acute Promyelocytic Leukemia. New England Journal of Medicine. 337(15). 1021–1028. 806 indexed citations breakdown →

14.

Mazza, J. J., John Hines, Janet W. Andersen, et al.. (1995). Aggressive Chemotherapy in the Treatment of Burkitt's and Non-BurKitt's Undifferentiated Lymphoma. Leukemia & lymphoma. 18(3-4). 289–296. 5 indexed citations

15.

Andersen, Janet W., et al.. (1993). Age and Hodgkin's disease: The impact of competing risks and possibly salvage therapy on long term survival: An E.C.O.G. study. Leukemia Research. 17(10). 825–832. 8 indexed citations

16.

Weisdorf, Daniel, Janet W. Andersen, J H Glick, & Martin M. Oken. (1992). Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation.. Journal of Clinical Oncology. 10(6). 942–947. 63 indexed citations

17.

Smalley, Richard V., Janet W. Andersen, Michael Hawkins, et al.. (1992). Interferon Alfa Combined with Cytotoxic Chemotherapy for Patients with Non-Hodgkin's Lymphoma. New England Journal of Medicine. 327(19). 1336–1341. 127 indexed citations

18.

Bennett, John M., Janet W. Andersen, & Peter A. Cassileth. (1991). Long term survival in acute myeloid leukemia: The eastern cooperative oncology group (ECOG) experience. Leukemia Research. 15(4). 223–227. 41 indexed citations

19.

Corey, Seth J., Janet W. Andersen, Gordon F. Vawter, Ernest E. Lack, & Stephen E. Sallan. (1991). Improved survival for children with anaplastic Wilms' tumors. Cancer. 68(5). 970–974. 8 indexed citations

20.

Licht, Jonathan D., Linda D. Bosserman, Janet W. Andersen, et al.. (1990). Treatment of low-grade and intermediate-grade lymphoma with intensive combination chemotherapy results in long-term, disease-free survival. Cancer. 66(4). 632–639. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact